Champions Oncology enters agreement with Weill Cornell Medicine

Champions Oncology announced a licensing agreement with Weill Cornell Medicine through the Center for Technology Licensing, part of Enterprise Innovation at Weill Cornell Medicine. This strategic collaboration will allow Champions Oncology to distribute and commercialize Weill Cornell Medicine’s extensive bank of hematological patient-derived xenograft models, generated by Dr. Giorgio Inghirami, Professor of Pathology and Laboratory Medicine at the institution and a member of the Englander Institute for Precision Medicine and Sandra and Edward Meyer Cancer Center. Through this agreement, Champions Oncology will hold exclusive rights, for a limited time, to offer services leveraging Weill Cornell Medicine’s models, and will serve as a repository to distribute these models to academic institutions worldwide. This collaboration enhances Champions Oncology’s commitment to providing cutting-edge solutions in the heme-oncology space.